Antibody-Dependent Cellular Phagocytosis by Macrophages is a Novel Mechanism of Action of Elotuzumab von Kurdi, Ahmed T, Glavey, Siobhan V, Bezman, Natalie A, Jhatakia, Amy, Guerriero, Jennifer L, Manier, Salomon, Moschetta, Michele, Mishima, Yuji, Roccaro, Aldo, Detappe, Alexandre, Liu, Chia-Jen, Sacco, Antonio, Huynh, Daisy, Tai, Yu-Tzu, Robbins, Michael D, Azzi, Jamil, Ghobrial, Irene M

Volltext

The anti-SLAMF7 antibody elotuzumab mediates NK cell activation through both CD16-dependent and -independent mechanisms von Pazina, Tatiana, James, Ashley M., MacFarlane, Alexander W., Bezman, Natalie A., Henning, Karla A., Bee, Christine, Graziano, Robert F., Robbins, Michael D., Cohen, Adam D., Campbell, Kerry S.

Volltext

Discovery of PF-04449913, a Potent and Orally Bioavailable Inhibitor of Smoothened von Munchhof, Michael J, Li, Qifang, Shavnya, Andrei, Borzillo, Gary V, Boyden, Tracey L, Jones, Christopher S, LaGreca, Susan D, Martinez-Alsina, Luis, Patel, Nandini, Pelletier, Kathleen, Reiter, Larry A, Robbins, Michael D, Tkalcevic, George T

Volltext

PD-1 blockade enhances elotuzumab efficacy in mouse tumor models von Bezman, Natalie A., Jhatakia, Amy, Kearney, Alper Y., Brender, Ty, Maurer, Mark, Henning, Karla, Jenkins, Misty R., Rogers, Amy J., Neeson, Paul J., Korman, Alan J., Robbins, Michael D., Graziano, Robert F.

Volltext

Development and Validation of Electrochemiluminescence Assays to Measure Free and Total sSLAMF7 in Human Serum in the Absence and Presence of Elotuzumab von Postelnek, Jennifer, Neely, Robert J., Robbins, Michael D., Gleason, Carol R., Peterson, Jon E., Piccoli, Steven P.

Volltext

A Phase Ib/II Trial of the First-in-Class Anti-CXCR4 Antibody Ulocuplumab in Combination with Lenalidomide or Bortezomib Plus Dexamethasone in Relapsed Multiple Myeloma von Ghobrial, Irene M, Liu, Chia-Jen, Redd, Robert A, Perez, Raymond P, Baz, Rachid, Zavidij, Oksana, Sklavenitis-Pistofidis, Romanos, Richardson, Paul G, Anderson, Kenneth C, Laubach, Jacob, Henrick, Patrick, Savell, Alexandra, Reyes, Kaitlen, Hornburg, Kalvis, Chuma, Stacey, Sabbatini, Peter, Robbins, Michael D, Becker, Pamela S

Volltext

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-α pathways von Balasa, Balaji, Yun, Rui, Belmar, Nicole A., Fox, Melvin, Chao, Debra T., Robbins, Michael D., Starling, Gary C., Rice, Audie G.

Volltext

The Effect of Elections on Public Opinion Toward Democracy: Evidence From Longitudinal Survey Research in Algeria von Robbins, Michael D. H., Tessler, Mark

Volltext

Alterations of NK Cell Phenotype in the Disease Course of Multiple Myeloma von Pazina, Tatiana, MacFarlane, 4th, Alexander W, Bernabei, Luca, Dulaimi, Essel, Kotcher, Rebecca, Yam, Clinton, Bezman, Natalie A, Robbins, Michael D, Ross, Eric A, Campbell, Kerry S, Cohen, Adam D

Volltext

The Role of Minimal Residual Disease Testing in Myeloma Treatment Selection and Drug Development: Current Value and Future Applications von Anderson, Kenneth C, Auclair, Daniel, Kelloff, Gary J, Sigman, Caroline C, Avet-Loiseau, Hervé, Farrell, Ann T, Gormley, Nicole J, Kumar, Shaji K, Landgren, Ola, Munshi, Nikhil C, Cavo, Michele, Davies, Faith E, Di Bacco, Alessandra, Dickey, Jennifer S, Gutman, Steven I, Higley, Howard R, Hussein, Mohamad A, Jessup, J Milburn, Kirsch, Ilan R, Little, Richard F, Loberg, Robert D, Lohr, Jens G, Mukundan, Lata, Omel, James L, Pugh, Trevor J, Reaman, Gregory H, Robbins, Michael D, Sasser, A Kate, Valente, Nancy, Zamagni, Elena

Volltext

What Leads Some Ordinary Arab Men and Women to Approve of Terrorist Acts against the United States? von Tessler, Mark, Robbins, Michael D. H.

Volltext

Enhanced SLAMF7 Homotypic Interactions by Elotuzumab Improves NK Cell Killing of Multiple Myeloma von Pazina, Tatiana, James, Ashley M, Colby, Kimberly B, Yang, Yibin, Gale, Andrew, Jhatakia, Amy, Kearney, Alper Y, Graziano, Robert F, Bezman, Natalie A, Robbins, Michael D, Cohen, Adam D, Campbell, Kerry S

Volltext

Aminopyrrolidineamide inhibitors of site-1 protease von Hay, Bruce A., Abrams, Barbara, Zumbrunn, Allice Y., Valentine, James J., Warren, Laurie C., Petras, Stephen F., Shelly, Lorraine D., Xia, Angela, Varghese, Alison H., Hawkins, Julie L., Van Camp, Jennifer A., Robbins, Michael D., Landschulz, Katherine, Harwood, H. James

Volltext

Regulation of Cytotoxic T Lymphocyte-Associated Molecule-4 by Src Kinases von Chuang, Ellen, Lee, Kyung-Mi, Robbins, Michael D, Duerr, James M, Alegre, Maria-Luisa, Hambor, John E, Neveu, Mark J, Bluestone, Jeffrey A, Thompson, Craig B

Volltext

Abstract 2998: Elotuzumab can costimulate NK cell responses by engaging SLAMF7 von Pazina, Tatiana, James, Ashley Mentlik, MacFarlane, Alexander W., Bezman, Natalie A., Graziano, Robert F., Robbins, Michael D., Cohen, Adam D., Campbell, Kerry S.

Volltext

Elotuzumab Promotes Self-Engagement of Signaling Lymphocytic Activation Molecule Family Member 7 (SLAMF7) Between Natural Killer (NK) and Multiple Myeloma (MM) Cells to Enhance Cyt... von Pazina, Tatiana, James, Ashley M., Jhatakia, Amy, Graziano, Robert F., Bezman, Natalie A., Robbins, Michael D., Cohen, Adam D., Campbell, Kerry S.

Volltext

The CD28 and CTLA-4 Receptors Associate with the Serine/Threonine Phosphatase PP2A von Chuang, Ellen, Fisher, Timothy S., Morgan, Rodney W., Robbins, Michael D., Duerr, James M., Vander Heiden, Matthew G., Gardner, Joseph P., Hambor, John E., Neveu, Mark J., Thompson, Craig B.

Volltext

Elotuzumab enhances natural killer cell activation and myeloma cell killing through interleukin-2 and TNF-[alpha] pathways von Balasa, Balaji, Yun, Rui, Belmar, Nicole A, Fox, Melvin, Chao, Debra T, Robbins, Michael D, Starling, Gary C, Rice, Audie G

Volltext

Abstract 4504: PF-04449913, a small molecule inhibitor of Hedgehog signaling, is effective in inhibiting tumor growth in preclinical models von Jackson-Fisher, Amy J., McMahon, Melissa J., Lam, Justine, Li, Chunze, Engstrom, Lars D., Tsaparikos, Konstantinos, Shields, David J., Fang, Douglas D., Lira, Maruja E., Zhu, Zhou, Robbins, Michael D., Schwab, Richard, Munchhof, Michael J., VanArsdale, Todd

Volltext

Advances in Psychotherapy of the Borderline Patient von ROBBINS, MICHAEL D

Volltext